Market Overview:
The global interventional neurology devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of neurological disorders, technological advancements in interventional neurology devices, and rising demand for minimally invasive procedures. By type, the global interventional neurology devices market is segmented into products and techniques. The products segment is further divided into carotid artery angioplasty and stenting systems, carotid artery stents, embolic protection systems (EPS), balloon occlusion devices (BODs), aneurysm coiling and embolization devices, flow diversion devices (FDDs), liquid embolic agents/devices (LEAs/DEs), embolic coils (ECs) micr-support Devices(MSDs) microcatheters. The techniques segment is further divided into angioplasty & stenting, neurothrombectomy procedures pre-operative tumor embolization therapies vertebroplasty stroke therapy). By application, the global interventional neurology device market is classified into arteriovenous malformation & fistulas cerebral aneurysms schemic strokes intracranial atherosclerotic disease).
Product Definition:
Interventional Neurology Devices are used to treat conditions of the nervous system. This can include things like treating a stroke, removing a tumor, or repairing damage to the spinal cord. Interventional neurology devices can be used in both open and minimally invasive procedures. The use of these devices is important because it allows for treatment of conditions that would otherwise be difficult or impossible to treat.
by Products:
By products, it's usage and growth factor in interventional neurology devices market is used for the treatment of neurological disorders such as stroke, brain tumor or aneurysm. The factors that propel the growth of this market include increasing prevalence of these diseases and technological advancement in diagnostics & therapeutics. Also byproducts have a wide range of applications which are used to treat various neurological disorders such as depression, Alzheimer’s disease or Parkinson’s disease.
Carotid Artery Angioplasty and Stenting:
Carotid artery angioplasty (CAA) stenting procedure is used to treat blockage or narrowing of the carotid artery. The carotid artery is a major blood vessel in the head that delivers oxygen-rich blood from the vertebrae to various parts of the brain. It also helps in removing waste products and toxins from the brain.
Application Insights:
The application segment includes aneurysm and other cerebrovascular diseases, arteriovenous malformations and fistulas, intracranial atherosclerotic disease (a.k.a., cerebral artery stenosis), stroke therapy, and others (such as spinal cord compression). Cerebral aneurysms are balloon-inflated sacs that develop on the brain arteries due to weak walls or a leaky blood vessel syndrome called aortic stenosis. The treatment of choice for cerebral aneurysms is surgical removal by opening up the skull through a craniotomy procedure or endoscopic clipping of the affected area followed by surgical closure using sutures or wires after sufficient healing time has passed.
Cerebral angioplasty.
Regional Analysis:
North America dominated the global interventional neurology devices market in 2017. This can be attributed to increasing prevalence of neurological disorders, rising preference for minimally invasive surgeries, and availability of highly skilled neurosurgeons and cardiologists. Moreover, growing awareness about various treatment options is anticipated to fuel the regional market during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure & facilities along with rising patient awareness levels regarding emerging treatments for cerebrovascular disorders are some others that can be attributed towards this growth rate in Asia Pacific region especially China India Japan Singapore South Korea Taiwan Thailand Vietnam Australia Indonesia Malaysia Philippines Brazil Argentina Mexico Colombia Venezuela Columbia And Middle East Saudi Arabia UAE Israel These countries have a large population base suffering from stroke disorder which needs proper treatment at an early stage thus leading towards higher revenue generation in this region over next eight years ‘08).
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is estimated to be around 6%–8%. This number is expected to grow due to the increasing aging population and changes in lifestyle. This will create a large pool of patients who will require treatment, thereby driving the demand for interventional neurology devices.
- Technological advancements: Interventional neurology devices are constantly evolving with new technologies being developed to improve patient outcomes. For instance, directional atherectomy systems are now available that can remove plaque from arteries more effectively and with less damage than traditional atherectomy systems. Such technological advancements will help drive the growth of the interventional neurology devices market.
- Growing demand for minimally invasive procedures: Minimally invasive procedures offer several advantages over traditional open surgery such as reduced pain, blood loss, and hospital stay duration. This has led to an increase in their popularity over the past few years, especially among patients who are apprehensive about undergoing surgery or those who have health conditions that preclude them from undergoing traditional open surgery procedures .This growing demand for minimally invasive procedures will help drive the growth of the interventional neurology devices market in coming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Interventional Neurology Devices Market Research Report
By Type
by Products, Carotid Artery Angioplasty and Stenting, Carotid Artery Stents, Embolic Protection Systems, Balloon Occlusion Devices, Aneurysm Coiling and Embolization Devices, Flow Diversion Devices, Liquid Embolic Devices, Embolic coils, Micr-Support Devices, Microcatheters, by Techniques, Angioplasty & Stenting, Neurothrombectomy, Pre-operative Tumor Embolization, Vertebroplasty, Stroke Therapy
By Application
Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Schemic Strokes, Intracranial Atherosclerotic Disease
By Companies
Abbott, DePuy Synthes, Medtronic, Stryker, Terumo, Acandis, Bayer, Boston Scientific, Biosensors International, evonos, Merit Medical Systems, MicroPort Scientific, Neurosign, Penumbra, Spiegelberg, Surtex Instruments
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Interventional Neurology Devices Market Report Segments:
The global Interventional Neurology Devices market is segmented on the basis of:
Types
by Products, Carotid Artery Angioplasty and Stenting, Carotid Artery Stents, Embolic Protection Systems, Balloon Occlusion Devices, Aneurysm Coiling and Embolization Devices, Flow Diversion Devices, Liquid Embolic Devices, Embolic coils, Micr-Support Devices, Microcatheters, by Techniques, Angioplasty & Stenting, Neurothrombectomy, Pre-operative Tumor Embolization, Vertebroplasty, Stroke Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Schemic Strokes, Intracranial Atherosclerotic Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- DePuy Synthes
- Medtronic
- Stryker
- Terumo
- Acandis
- Bayer
- Boston Scientific
- Biosensors International
- evonos
- Merit Medical Systems
- MicroPort Scientific
- Neurosign
- Penumbra
- Spiegelberg
- Surtex Instruments
Highlights of The Interventional Neurology Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- by Products
- Carotid Artery Angioplasty and Stenting
- Carotid Artery Stents
- Embolic Protection Systems
- Balloon Occlusion Devices
- Aneurysm Coiling and Embolization Devices
- Flow Diversion Devices
- Liquid Embolic Devices
- Embolic coils
- Micr-Support Devices
- Microcatheters
- by Techniques
- Angioplasty & Stenting
- Neurothrombectomy
- Pre-operative Tumor Embolization
- Vertebroplasty
- Stroke Therapy
- By Application:
- Arteriovenous Malformation and Fistulas
- Cerebral Aneurysms
- Schemic Strokes
- Intracranial Atherosclerotic Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Interventional Neurology Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Interventional neurology devices are medical devices that are inserted into the body to treat neurological conditions. These devices can include stents, pacemakers, and implantable defibrillators.
Some of the major companies in the interventional neurology devices market are Abbott, DePuy Synthes, Medtronic, Stryker, Terumo, Acandis, Bayer, Boston Scientific, Biosensors International, evonos, Merit Medical Systems, MicroPort Scientific, Neurosign, Penumbra, Spiegelberg, Surtex Instruments.
The interventional neurology devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Interventional Neurology Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Interventional Neurology Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Interventional Neurology Devices Market - Supply Chain
4.5. Global Interventional Neurology Devices Market Forecast
4.5.1. Interventional Neurology Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Interventional Neurology Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Interventional Neurology Devices Market Absolute $ Opportunity
5. Global Interventional Neurology Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Interventional Neurology Devices Market Size and Volume Forecast by Type
5.3.1. by Products
5.3.2. Carotid Artery Angioplasty and Stenting
5.3.3. Carotid Artery Stents
5.3.4. Embolic Protection Systems
5.3.5. Balloon Occlusion Devices
5.3.6. Aneurysm Coiling and Embolization Devices
5.3.7. Flow Diversion Devices
5.3.8. Liquid Embolic Devices
5.3.9. Embolic coils
5.3.10. Micr-Support Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Interventional Neurology Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Interventional Neurology Devices Market Size and Volume Forecast by Application
6.3.1. Arteriovenous Malformation and Fistulas
6.3.2. Cerebral Aneurysms
6.3.3. Schemic Strokes
6.3.4. Intracranial Atherosclerotic Disease
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Interventional Neurology Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Interventional Neurology Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Interventional Neurology Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Interventional Neurology Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Interventional Neurology Devices Demand Share Forecast, 2019-2029
9. North America Interventional Neurology Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Interventional Neurology Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Interventional Neurology Devices Market Size and Volume Forecast by Application
9.4.1. Arteriovenous Malformation and Fistulas
9.4.2. Cerebral Aneurysms
9.4.3. Schemic Strokes
9.4.4. Intracranial Atherosclerotic Disease
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Interventional Neurology Devices Market Size and Volume Forecast by Type
9.7.1. by Products
9.7.2. Carotid Artery Angioplasty and Stenting
9.7.3. Carotid Artery Stents
9.7.4. Embolic Protection Systems
9.7.5. Balloon Occlusion Devices
9.7.6. Aneurysm Coiling and Embolization Devices
9.7.7. Flow Diversion Devices
9.7.8. Liquid Embolic Devices
9.7.9. Embolic coils
9.7.10. Micr-Support Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Interventional Neurology Devices Demand Share Forecast, 2019-2029
10. Latin America Interventional Neurology Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Interventional Neurology Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Interventional Neurology Devices Market Size and Volume Forecast by Application
10.4.1. Arteriovenous Malformation and Fistulas
10.4.2. Cerebral Aneurysms
10.4.3. Schemic Strokes
10.4.4. Intracranial Atherosclerotic Disease
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Interventional Neurology Devices Market Size and Volume Forecast by Type
10.7.1. by Products
10.7.2. Carotid Artery Angioplasty and Stenting
10.7.3. Carotid Artery Stents
10.7.4. Embolic Protection Systems
10.7.5. Balloon Occlusion Devices
10.7.6. Aneurysm Coiling and Embolization Devices
10.7.7. Flow Diversion Devices
10.7.8. Liquid Embolic Devices
10.7.9. Embolic coils
10.7.10. Micr-Support Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Interventional Neurology Devices Demand Share Forecast, 2019-2029
11. Europe Interventional Neurology Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Interventional Neurology Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Interventional Neurology Devices Market Size and Volume Forecast by Application
11.4.1. Arteriovenous Malformation and Fistulas
11.4.2. Cerebral Aneurysms
11.4.3. Schemic Strokes
11.4.4. Intracranial Atherosclerotic Disease
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Interventional Neurology Devices Market Size and Volume Forecat by Type
11.7.1. by Products
11.7.2. Carotid Artery Angioplasty and Stenting
11.7.3. Carotid Artery Stents
11.7.4. Embolic Protection Systems
11.7.5. Balloon Occlusion Devices
11.7.6. Aneurysm Coiling and Embolization Devices
11.7.7. Flow Diversion Devices
11.7.8. Liquid Embolic Devices
11.7.9. Embolic coils
11.7.10. Micr-Support Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Interventional Neurology Devices Demand Share, 2019-2029
12. Asia Pacific Interventional Neurology Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Interventional Neurology Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Interventional Neurology Devices Market Size and Volume Forecast by Application
12.4.1. Arteriovenous Malformation and Fistulas
12.4.2. Cerebral Aneurysms
12.4.3. Schemic Strokes
12.4.4. Intracranial Atherosclerotic Disease
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Interventional Neurology Devices Market Size and Volume Forecast by Type
12.7.1. by Products
12.7.2. Carotid Artery Angioplasty and Stenting
12.7.3. Carotid Artery Stents
12.7.4. Embolic Protection Systems
12.7.5. Balloon Occlusion Devices
12.7.6. Aneurysm Coiling and Embolization Devices
12.7.7. Flow Diversion Devices
12.7.8. Liquid Embolic Devices
12.7.9. Embolic coils
12.7.10. Micr-Support Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Interventional Neurology Devices Demand Share, 2019-2029
13. Middle East & Africa Interventional Neurology Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Interventional Neurology Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Interventional Neurology Devices Market Size and Volume Forecast by Application
13.4.1. Arteriovenous Malformation and Fistulas
13.4.2. Cerebral Aneurysms
13.4.3. Schemic Strokes
13.4.4. Intracranial Atherosclerotic Disease
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Interventional Neurology Devices Market Size and Volume Forecast by Type
13.7.1. by Products
13.7.2. Carotid Artery Angioplasty and Stenting
13.7.3. Carotid Artery Stents
13.7.4. Embolic Protection Systems
13.7.5. Balloon Occlusion Devices
13.7.6. Aneurysm Coiling and Embolization Devices
13.7.7. Flow Diversion Devices
13.7.8. Liquid Embolic Devices
13.7.9. Embolic coils
13.7.10. Micr-Support Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Interventional Neurology Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Interventional Neurology Devices Market: Market Share Analysis
14.2. Interventional Neurology Devices Distributors and Customers
14.3. Interventional Neurology Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DePuy Synthes
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Stryker
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Terumo
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Acandis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bayer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Boston Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biosensors International
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. evonos
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Merit Medical Systems
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. MicroPort Scientific
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Neurosign
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Penumbra
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Spiegelberg
14.4.15.1.